These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 26732270

  • 1. Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
    Nakayama S, Amiry-Moghaddam M, Ottersen OP, Bhardwaj A.
    Neurocrit Care; 2016 Apr; 24(2):273-82. PubMed ID: 26732270
    [Abstract] [Full Text] [Related]

  • 2. Osmotherapy With Hypertonic Saline Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
    Nakayama S, Migliati E, Amiry-Moghaddam M, Ottersen OP, Bhardwaj A.
    Crit Care Med; 2016 Aug; 44(8):e702-10. PubMed ID: 27035238
    [Abstract] [Full Text] [Related]

  • 3. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
    Zeynalov E, Jones SM, Seo JW, Snell LD, Elliott JP.
    PLoS One; 2015 Aug; 10(8):e0136121. PubMed ID: 26275173
    [Abstract] [Full Text] [Related]

  • 4. Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.
    Zeynalov E, Jones SM, Elliott JP.
    J Vis Exp; 2016 Sep 01; (115):. PubMed ID: 27684044
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice.
    Zeynalov E, Jones SM, Elliott JP.
    PLoS One; 2017 Sep 01; 12(8):e0183985. PubMed ID: 28854286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Na(+)-K (+)-2Cl (-) cotransport inhibitor attenuates cerebral edema following experimental stroke via the perivascular pool of aquaporin-4.
    Migliati ER, Amiry-Moghaddam M, Froehner SC, Adams ME, Ottersen OP, Bhardwaj A.
    Neurocrit Care; 2010 Aug 01; 13(1):123-31. PubMed ID: 20458553
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cerebral cortical aquaporin-4 expression in brain edema following cardiac arrest in rats.
    Xiao F, Arnold TC, Zhang S, Brown C, Alexander JS, Carden DL, Conrad SA.
    Acad Emerg Med; 2004 Oct 01; 11(10):1001-7. PubMed ID: 15466140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of sex-linked differences in cerebral edema and aquaporin-4 expression after experimental stroke.
    Liu X, Zhang W, Alkayed NJ, Froehner SC, Adams ME, Amiry-Moghaddam M, Ottersen OP, Hurn PD, Bhardwaj A.
    J Cereb Blood Flow Metab; 2008 Dec 01; 28(12):1898-906. PubMed ID: 18648381
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.
    Okuno K, Taya K, Marmarou CR, Ozisik P, Fazzina G, Kleindienst A, Gulsen S, Marmarou A.
    Acta Neurochir Suppl; 2008 Dec 01; 102():431-6. PubMed ID: 19388361
    [Abstract] [Full Text] [Related]

  • 15. Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature.
    Hedna VS, Bidari S, Gubernick D, Ansari S, Satriotomo I, Khan AA, Qureshi AI.
    BMC Neurol; 2014 Nov 18; 14():213. PubMed ID: 25403760
    [Abstract] [Full Text] [Related]

  • 16. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
    Kleindienst A, Dunbar JG, Glisson R, Marmarou A.
    Acta Neurochir (Wien); 2013 Jan 18; 155(1):151-64. PubMed ID: 23188468
    [Abstract] [Full Text] [Related]

  • 17. The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.
    Decker D, Collier L, Lau T, Olivera R, Roma G, Leonardo C, Seifert H, Rowe D, Pennypacker KR.
    Acta Neurochir Suppl; 2016 Jan 18; 121():243-50. PubMed ID: 26463956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury.
    Krieg SM, Trabold R, Plesnila N.
    J Neurotrauma; 2017 Apr 01; 34(7):1329-1336. PubMed ID: 27762660
    [Abstract] [Full Text] [Related]

  • 20. A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells.
    Dou D, Ji Y, Zheng J, Li J, Zhu X, Tang S, Wang H, Li Q, Jing H.
    Dig Dis Sci; 2022 Aug 01; 67(8):3683-3692. PubMed ID: 34751838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.